Innovation meets quality: moving cellular therapies at the National Institutes for Health from bench to bedside

ISSN： 1465-3249

Source： Cytotherapy, Vol.6, Iss.6, 2004-12, pp. : 626-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The transition from bench to bedside: lessons learned in the creation of a new T-cell product for the clinic

By Barrett J Solomon S

Cytotherapy, Vol. 6, Iss. 6, 2004-12 ,pp. : 593-595

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Governmental, national, international agency and other eliminate initiatives to advance the application of cellular therapies

Cytotherapy, Vol. 7, Iss. 4, 2005-09 ,pp. : 315-316

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Regulatory issues in cellular therapies

By Sharp Jg

Cytotherapy, Vol. 5, Iss. 4, 2003-08 ,pp. : 277-278

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Regulation of cellular therapies: the Australian perspective

By Wall Dmp Prince Hm

Cytotherapy, Vol. 5, Iss. 4, 2003-08 ,pp. : 284-288

Ashgate Publishing Ltd

Access to resources Recommend Favorite

The use of T-cell directed cellular therapies in Australia

By Moss Dj Khanna R. Gandhi M.

Cytotherapy, Vol. 9, Iss. 3, 2007-01 ,pp. : 222-224

Ashgate Publishing Ltd

Access to resources Recommend Favorite